• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Thursday, January 28, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

ALSA Ventures launches European biotech clinical accelerator ‘Eclipse’

Bioengineer by Bioengineer
October 13, 2020
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

ALSA Ventures, a London based European biotech investment firm today announced the launch of Eclipse, a novel clinical development accelerator focused on therapeutics assets in late preclinical development.

IMAGE

Credit: ALSA Ventures

London, UK – ALSA Ventures, a London based European biotech investment firm today announced the launch of Eclipse, a novel clinical development accelerator focused on therapeutics assets in late preclinical development.

ALSA Ventures CEO Alek Safarian said:

“Our model is to work very closely with management teams we invest in. We have considerable bench strength in clinical development experience within the ALSA team, so launching this Accelerator makes a lot of sense on a number of levels.”

Under the Eclipse framework, eligible companies will be selected for equity investment and funding through ALSA’s inaugural fund, ALSA Ventures I SCSp. Applications will be assessed on a competitive basis quarterly, with equity investment of up to $5M offered to awarded companies. Upon receipt of this investment, awarded companies will work with global clinical research organisation ICON to progress their asset through first-in-man studies.

“We are very pleased to have ICON, a leading global provider of outsourced clinical services, support the Eclipse initiative with capabilities across the full spectrum of consulting and clinical development services,” said Safarian.

The Eclipse development programme will invest in novel therapeutic drugs that aim to solve high unmet need, and will focus on scientific innovation in the UK and Europe.

To learn more about the application process and how the Eclipse model works visit: https://www.alsaventures.com/eclipse/summary

###

About ALSA Ventures http://www.alsaventures.com

ALSA Ventures is a UK and EU biotechnology investment firm with a focus on novel therapeutics at preclinical POC or early clinical development stage. The firm was established in 2019, by Alek Safarian, founder and ex-CEO of clinical CRO, Novotech. ALSA Ventures recently announced the first closing of its European biotechnology investment fund, and has made three investments to date.

Media contact:

Susan Fitzpatrick-Napier

[email protected]

Media Contact
Susan Fitzpatrick-Napier
[email protected]

Original Source

https://www.alsaventures.com/eclipse/summary

Tags: BiotechnologycancerClinical TrialsGrants/FundingImmunology/Allergies/AsthmaInfectious/Emerging DiseasesInternal MedicineMedicine/HealthMetabolism/Metabolic Diseasesneurobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

Scientists publish a blueprint to apply artificial intelligence to extend human longevity

January 27, 2021
IMAGE

Using wearable tech to keep babies, pregnant women healthy

January 27, 2021

Adults with cognitive disabilities more than twice as likely to use e-cigarettes

January 27, 2021

New study points to better diagnostics for cancer

January 27, 2021
Next Post
IMAGE

Study first to tally biomass from oceanic plastic debris using visualization method

IMAGE

University of Cincinnati researcher examines genetic role in addiction

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    54 shares
    Share 22 Tweet 14
  • People living with HIV face premature heart disease and barriers to care

    69 shares
    Share 28 Tweet 17
  • New drug form may help treat osteoporosis, calcium-related disorders

    41 shares
    Share 16 Tweet 10
  • New findings help explain how COVID-19 overpowers the immune system

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Chemistry/Physics/Materials SciencesInfectious/Emerging DiseasesGeneticsEcology/EnvironmentcancerTechnology/Engineering/Computer ScienceClimate ChangeMaterialsPublic HealthBiologyMedicine/HealthCell Biology

Recent Posts

  • Scientists publish a blueprint to apply artificial intelligence to extend human longevity
  • In Brazil, many smaller dams disrupt fish more than large hydropower projects
  • New NCAR-Wyoming supercomputer to accelerate scientific discovery
  • Putting bugs on the menu, safely
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In